- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00549380
Clinical Study of Aneurysm Exclusion (Endologix)
A Clinical Study of Aneurysm Exclusion Using Endologix, Inc. Endoluminal Technology
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study is to examine the feasibility of expanded applications of the basic Endologix technology for the treatment of arterial aneurysmal disease. A second objective of this study is to gather data in order to make logical, scientific recommendations for device design, construction and application which will expand the application of the endoluminal graft technology and improve its safety and efficacy while expanding the several potential future positive aspects of a less invasive method of treating arterial occlusive disease.
Endologix, Inc. has applied for and received an IDE for the investigation of a bifurcated device to exclude aneurysms of the abdominal aorta. The Arizona Heart Institute experience indicates that this small study design will prove successful. Using the basic technology of the current approved IDE, it is Arizona Heart Institute's intention to expand the scope of application and design in order to address a greater population basis suffering from aneurysmal disease. In this regard, the basic Endologix device designs will be applied to appropriate patients beyond the scope of the current bifurcated IDE. Patients meeting the criteria for the Endologix IDE will be enrolled independently in that study and followed precisely in order to comply with the study design. Patients with aneurysmal disease not currently filling the criteria for a bifurcated abdominal aortic prosthetic but who could potentially benefit from the technology to exclude aneurysmal disease will be considered from this study.
The patient's participation in the Study will include enrollment, Investigational Device procedure and follow-up period. Patient data will be collected for 1, 6, and 12 months and beyond as indicated. Subject follow-up at 1 month will include; ABIs, a complete Physical Examination, Duplex Ultrasound, and X-ray. Subject follow-up at 6 and 12 months will also include ABIs, a complete Physical Examination, CT Scan-Contrast Enhanced (unless contraindicated), CT Scan-No Contrast, and X-ray.
Study Type
Enrollment (Anticipated)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85006
- Arizona Heart Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ≥ 18 years old
- Informed consent understood and signed.
- Compliance with post-treatment follow-up requirements.
- Candidates in this study may not be ideal surgical patients and therefore may be included based upon the recommendation of the principal investigator or co-investigators and one independent consultant confirming the opinion of the investigators.
- Patient may present as an emergency or urgent use patient with indications including: ruptured aneurysm, dissected artery, or transected artery.
Exclusion Criteria:
- Life expectancy < 2 years.
- Pregnant or lactating women.
- Indication that appropriate follow-up studies would for whatever reason be difficult to obtain.
- Patient has other medical or psychiatric problems, which in the opinion of the investigator, precludes them from participating in the study.
- Anticoagulation drugs are indicated.
- Coagulopathy or bleeding disorder.
- Active systemic or localized groin infection.
- Inferior mesenteric artery is indispensable.
- Creatinine level > 1.7 mg/dl.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
|
Stent-graft endoprosthesis is inserted by Delivery System via a surgical cutdown (e.g., external iliac artery, femoral artery, common iliac artery conduit, etc.) approach.
The insertion method depends on each patient's anatomy and is determined by the Clinical Investigator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility applications
Time Frame: Index procedure and discharge following index procedure
|
The primary objective of this study is to examine the feasibility of expanded applications of the basic Endologix technology for the treatment of arterial aneurysmal disease.
|
Index procedure and discharge following index procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Data collection
Time Frame: 1 month
|
A secondary objective of this study is to gather data in order to make logical, scientific recommendations for device design, construction, and application which will: a) expand the application of the endoluminal graft technology and b) improve its safety and efficacy while c) expanding the several potential future aspects of a less invasive method of treating arterial disease.
|
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- G990189
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aneurysm
-
University of BolognaCompletedThoracoabdominal Aortic Aneurysm | Ruptured Thoracic Aneurysm | Ruptured Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm, RupturedItaly
-
University of North Carolina, Chapel HillCook Group Incorporated; UNC HospitalsEnrolling by invitationAortic Aneurysm, Abdominal | Aortic Arch Aneurysm | Ascending Aorta AneurysmUnited States
-
IRCCS San RaffaeleCompletedAneurysm Thoracic | Aneurysm Abdominal | Renal AneurysmUnited States, France, Italy, United Kingdom, Germany, Spain, Denmark, Sweden
-
Baptist Health South FloridaWilliam Cook AustraliaRecruitingThoracoabdominal Aortic Aneurysm | Aortic Arch AneurysmUnited States
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysm (AAA) | Aorto-iliac Aneurysm | Juxtarenal AneurysmUnited States
-
University of California, San DiegoRecruitingJuxtarenal Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm | Pararenal Aortic Aneurysm | Complex Abdominal Aortic AneurysmUnited States
-
JOTEC GmbHRecruiting
-
The Christ HospitalMedtronicRecruiting
-
Karolinska University HospitalEnrolling by invitationAneurysm | Aortic Aneurysm | Abdominal Aortic Aneurysm, Ruptured | Aneurysm Abdominal | Abdominal Aortic Aneurysm Without RuptureSweden
-
Matthew EagletonMassachusetts General HospitalEnrolling by invitationAortic Dissection | Ascending Aortic Dissection | Thoracoabdominal Aortic Aneurysm | Thoracic Aortic Aneurysms | Dissecting, Aneurysm | Ascending Aorta Aneurysm | Aortic Arch; Aneurysm, Dissecting | Renal Artery Aneurysm | Superior Mesenteric Artery AneurysmUnited States
Clinical Trials on Endologix, Inc. Endoluminal Technology
-
Merit Medical Systems, Inc.University of Colorado, Denver; Mayo Clinic; University of Florida; Medical College... and other collaboratorsCompletedMalignant Esophageal StricturesUnited States
-
Ethicon Endo-SurgeryTerminated
-
Stanford UniversityCompletedBreast Cancer | LymphedemaUnited States
-
University of Turin, ItalyCompletedMaxillary Transverse Deficiency (MTD)Italy
-
University of Southern DenmarkOdense University Hospital; University of Salford; Sygehus Lillebaelt; Region of... and other collaboratorsCompleted
-
Midwest Biomedical Research FoundationWashington University School of Medicine; University of Chicago; Columbia University and other collaboratorsTerminatedEsophageal Neoplasms | Barrett's EsophagusUnited States
-
Cairo UniversityNot yet recruitingCaries, Dental | Remineralization | White Spot Lesion
-
Polish Hernia Study GroupTerminatedHernia, Abdominal | Hernia,VentralPoland